ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30 | -99.9% | 225 | 0.0% | 0.02% | +10.0% |
| Q3 2022 | $26,000 | 0.0% | 225 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $26,000 | -10.3% | 225 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $29,000 | -14.7% | 225 | 0.0% | 0.02% | -14.3% |
| Q4 2021 | $34,000 | -5.6% | 225 | 0.0% | 0.02% | -12.5% |
| Q3 2021 | $36,000 | -2.7% | 225 | 0.0% | 0.02% | -4.0% |
| Q2 2021 | $37,000 | +8.8% | 225 | 0.0% | 0.02% | -3.8% |
| Q1 2021 | $34,000 | -26.1% | 225 | -25.5% | 0.03% | -35.0% |
| Q4 2020 | $46,000 | +12.2% | 302 | 0.0% | 0.04% | +2.6% |
| Q3 2020 | $41,000 | -14.6% | 302 | -14.2% | 0.04% | -25.0% |
| Q2 2020 | $48,000 | +26.3% | 352 | 0.0% | 0.05% | +8.3% |
| Q1 2020 | $38,000 | +40.7% | 352 | +56.4% | 0.05% | +77.8% |
| Q4 2019 | $27,000 | +17.4% | 225 | 0.0% | 0.03% | +22.7% |
| Q3 2019 | $23,000 | -4.2% | 225 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $24,000 | -4.0% | 225 | 0.0% | 0.02% | -8.3% |
| Q1 2019 | $25,000 | 0.0% | 225 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $25,000 | – | 225 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |